Clinical Trial Update: Panitumumab Regimen Evaluation in Colorectal Cancer to Estimate Primary Response to Treatment [Phase 2]

View source ↗

Summary

This update reports results from a Phase 2 trial evaluating panitumumab regimens in colorectal cancer to estimate the primary treatment response. Results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Panitumumab (panitumumab)

Snippet

Sponsor: Amgen | Conditions: Colon Cancer, Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-02-15